Literature DB >> 3770275

Effect of metformin on glucose metabolism in mouse soleus muscle.

C J Bailey, J A Puah.   

Abstract

To investigate the antihyperglycaemic effect of metformin (dimethylbiguanide), insulin binding and glucose metabolism were examined in soleus muscles isolated from streptozotocin diabetic mice. Treatment with metformin (250 mg/kg/day orally for 3 weeks) reduced by 39% the severity of streptozotocin-induced hyperglycaemia. Soleus muscles of metformin treated mice showed a 41% increase in total insulin receptor number, and a 20% increase in 3-0-methylglucose uptake at both submaximally and maximally stimulating insulin concentrations. Oxidation of U-14C-glucose to 14CO2 and the formation of 14C-glycogen were increased by 25% and 30% respectively at maximally stimulating insulin concentrations, but not at submaximally stimulating concentrations. Lactate formation was not significantly altered. Maximum activity of hexokinase (EC 2.7.1.1) was increased by 35%, and this effect was independent of insulin. The results suggest that the antihyperglycaemic effect of metformin in streptozotocin diabetic mice is related in part to an increase in insulin-mediated glucose uptake and oxidative metabolism in skeletal muscle.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3770275

Source DB:  PubMed          Journal:  Diabete Metab        ISSN: 0338-1684


  24 in total

1.  Metformin: historical overview.

Authors:  Clifford J Bailey
Journal:  Diabetologia       Date:  2017-08-03       Impact factor: 10.122

Review 2.  The biochemistry of diabetes.

Authors:  R Taylor; L Agius
Journal:  Biochem J       Date:  1988-03-15       Impact factor: 3.857

Review 3.  The antihyperglycaemic effect of metformin: therapeutic and cellular mechanisms.

Authors:  N F Wiernsperger; C J Bailey
Journal:  Drugs       Date:  1999       Impact factor: 9.546

4.  Effects of metformin treatment on glucose transporter proteins in subcellular fractions of skeletal muscle in (fa/fa) Zucker rats.

Authors:  J Rouru; M Koulu; J Peltonen; E Santti; V Hänninen; U Pesonen; R Huupponen
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

5.  Role of metformin in the management of polycystic ovary syndrome.

Authors:  Hany Lashen
Journal:  Ther Adv Endocrinol Metab       Date:  2010-06       Impact factor: 3.565

Review 6.  Therapeutic Potential of Antidiabetic Medications in the Treatment of Cognitive Dysfunction and Dementia.

Authors:  Hiroyuki Umegaki
Journal:  Drugs Aging       Date:  2016-06       Impact factor: 3.923

7.  Glucose transport in human skeletal muscle cells in culture. Stimulation by insulin and metformin.

Authors:  V Sarabia; L Lam; E Burdett; L A Leiter; A Klip
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

8.  AMP-activated protein kinase regulates nicotinamide phosphoribosyl transferase expression in skeletal muscle.

Authors:  Josef Brandauer; Sara G Vienberg; Marianne A Andersen; Stine Ringholm; Steve Risis; Per S Larsen; Jonas M Kristensen; Christian Frøsig; Lotte Leick; Joachim Fentz; Sebastian Jørgensen; Bente Kiens; Jørgen F P Wojtaszewski; Erik A Richter; Juleen R Zierath; Laurie J Goodyear; Henriette Pilegaard; Jonas T Treebak
Journal:  J Physiol       Date:  2013-08-05       Impact factor: 5.182

9.  Insulin requirement for the antihyperglycaemic effect of metformin.

Authors:  C J Bailey; K J Mynett
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739

10.  Effect of metformin on insulin-stimulated glucose transport in isolated skeletal muscle obtained from patients with NIDDM.

Authors:  D Galuska; L A Nolte; J R Zierath; H Wallberg-Henriksson
Journal:  Diabetologia       Date:  1994-08       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.